Literature DB >> 20420849

Interactions between morphine, scopolamine and nicotine: schedule-controlled responding in rats.

Xinwang Li1, Jun-Xu Li, Charles P France.   

Abstract

Functional interactions between drugs acting on either opioid or cholinergic systems have been demonstrated for both neurochemical and behavioral measures. This study used schedule-controlled responding and isobolographic analyses to examine interactions between the micro opioid receptor agonist morphine and the muscarinic acetylcholine receptor antagonist scopolamine as well as the nicotinic acetylcholine receptor agonist nicotine. In 8 rats responding under a fixed ratio 5 schedule of food presentation, morphine (3.2-10mg/kg), scopolamine (0.032-1.0mg/kg), and nicotine (0.1-1mg/kg) each dose-dependently decreased responding. Acute injection of scopolamine shifted the morphine dose-response curved leftward and downward and acute injection of morphine shifted the scopolamine and nicotine dose-response curves leftward and downward. The interaction between morphine and nicotine was additive; however, the interaction between morphine and scopolamine was infra-additive or supra-additive, depending on whether scopolamine or morphine was administered first. These results provide quantitative evidence regarding potentially important interactions between drugs acting on either opioid or cholinergic systems, although these interactions are modest and appear to depend on the specific conditions of drug administration. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20420849      PMCID: PMC2880219          DOI: 10.1016/j.pbb.2010.04.011

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  26 in total

1.  Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice.

Authors:  Weilie Zhang; Masahisa Yamada; Jesus Gomeza; Anthony S Basile; Jürgen Wess
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

2.  Reversal of morphine-induced memory impairment in mice by withdrawal in Morris water maze: possible involvement of cholinergic system.

Authors:  Z Li; C F Wu; G Pei; N J Xu
Journal:  Pharmacol Biochem Behav       Date:  2001-03       Impact factor: 3.533

3.  Cross-tolerance between morphine- and nicotine-induced conditioned place preference in mice.

Authors:  Mohammad Reza Zarrindast; Nasrin Faraji; Parvin Rostami; Hedayat Sahraei; Hassan Ghoshouni
Journal:  Pharmacol Biochem Behav       Date:  2003-01       Impact factor: 3.533

4.  Effects of humoral modulators and naloxone on morphine-induced changes in the spontaneous locomotor activity of the rat.

Authors:  T Oka; E Hosoya
Journal:  Psychopharmacology (Berl)       Date:  1976-06-23       Impact factor: 4.530

5.  Reactivation of morphine conditioned place preference by drug priming: role of environmental cues and sensitization.

Authors:  Lin Lu; Nan-Jie Xu; Xin Ge; Wen Yue; Wen-Juan Su; Gang Pei; Lan Ma
Journal:  Psychopharmacology (Berl)       Date:  2001-09-14       Impact factor: 4.530

6.  The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies.

Authors:  Lawrence P Carter; Lauren R Flores; Huifang Wu; Weibin Chen; Andrew W Unzeitig; Andy Coop; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2003-02-11       Impact factor: 4.030

7.  Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior.

Authors:  R A Harris
Journal:  J Pharmacol Exp Ther       Date:  1980-06       Impact factor: 4.030

8.  Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha 3 beta 4 nicotinic receptors.

Authors:  Stanley D Glick; Isabelle M Maisonneuve; Barbara A Kitchen
Journal:  Eur J Pharmacol       Date:  2002-07-19       Impact factor: 4.432

9.  The impairment of retention induced by beta-endorphin in mice may be mediated by a reduction of central cholinergic activity.

Authors:  I B Introini; C M Baratti
Journal:  Behav Neural Biol       Date:  1984-07

10.  Interactions between Delta(9)-tetrahydrocannabinol and mu opioid receptor agonists in rhesus monkeys: discrimination and antinociception.

Authors:  Jun-Xu Li; Lance R McMahon; Lisa R Gerak; Ginger L Becker; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2008-05-10       Impact factor: 4.530

View more
  5 in total

Review 1.  The Cholinergic System as a Treatment Target for Opioid Use Disorder.

Authors:  Kevin P Jensen; Elise E DeVito; Sarah Yip; Kathleen M Carroll; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2018-11       Impact factor: 5.749

2.  Assessing physiological dependence and withdrawal potential of mitragynine using schedule-controlled behaviour in rats.

Authors:  Norsyifa Harun; Illa Syafiqah Johari; Sharif Mahsufi Mansor; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2019-12-12       Impact factor: 4.530

3.  Cross State-dependent Learning Interaction Between Scopolamine and Morphine in Mice: The Role of Dorsal Hippocampus.

Authors:  Morteza Maleki; Majid Hassanpour-Ezatti; Majid Navaeian
Journal:  Basic Clin Neurosci       Date:  2017 May-Jun

4.  Interaction of nicotine with morphine potency in Paramecium caudatum.

Authors:  Seyed Sajad Shahrokhi; Mahnaz Kesmati; Bahram Kazemi
Journal:  Heliyon       Date:  2019-08-23

5.  Ascorbic Acid interaction with analgesic effect of morphine and tramadol in mice.

Authors:  Fatemeh Zeraati; Malihe Araghchian; Mohammad Hadi Farjoo
Journal:  Anesth Pain Med       Date:  2014-06-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.